WHO ICTRP trial
This study compares nebulized magnesium sulfate and nebulized lignocaine to see…
CTRI/2024/07/071588 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/07/071588 |
|---|---|
| Public title | This study compares nebulized magnesium sulfate and nebulized lignocaine to see which better to control heart rate ,blood pressure ,mean arterial pressure and spo2 , when they get a tube put into trachea and ventilated during surgery. |
| Scientific title | Nebulised magnesium sulphate v/s nebulised 2 percent lignocaine for attenuation of hemodynamic stress response to laryngoscopy and tracheal intubation: A prospective randomised double blinded ,comparative study - Nil |
| Primary sponsor | Dr Ashwitha P |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: O- Medical and Surgical |
| Interventions | Intervention1: Magnesium sulphate: Magnesium sulfate is a magnesium salt having sulfate as the counterion. It has a role as an anticonvulsant, a cardiovascular drug, a calcium channel blocker, an anaesthetic, a tocolytic agent, an… |
| Registration date | Jul 30, 2024 |
| Target size | 128 |
| Secondary IDs | Nil |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: